| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012 | 958 | 2012 |
| Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis EC Stack, C Wang, KA Roman, CC Hoyt Methods 70 (1), 46-58, 2014 | 754 | 2014 |
| The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis A Pettersson, RE Graff, SR Bauer, MJ Pitt, RT Lis, EC Stack, NE Martin, ... Cancer epidemiology, biomarkers & prevention 21 (9), 1497-1509, 2012 | 363 | 2012 |
| Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma CD Carey, D Gusenleitner, M Lipschitz, MGM Roemer, EC Stack, E Gjini, ... Blood, The Journal of the American Society of Hematology 130 (22), 2420-2430, 2017 | 319 | 2017 |
| Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib N Wagle, BC Grabiner, EM Van Allen, E Hodis, S Jacobus, JG Supko, ... Cancer discovery 4 (5), 546-553, 2014 | 298 | 2014 |
| Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice EC Stack, JK Kubilus, K Smith, K Cormier, SJ Del Signore, E Guelin, ... Journal of Comparative Neurology 490 (4), 354-370, 2005 | 290 | 2005 |
| Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and … TK Choueiri, S Jacobus, J Bellmunt, A Qu, LJ Appleman, C Tretter, ... Journal of clinical oncology 32 (18), 1889-1894, 2014 | 287 | 2014 |
| Novel technologies and emerging biomarkers for personalized cancer immunotherapy J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ... Journal for immunotherapy of cancer 4, 1-25, 2016 | 268 | 2016 |
| The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... Journal for immunotherapy of cancer 8 (1), 2020 | 208 | 2020 |
| Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants EC Stack, WR Matson, RJ Ferrante Annals of the New York Academy of Sciences 1147 (1), 79-92, 2008 | 198 | 2008 |
| A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer A Lunardi, U Ala, MT Epping, L Salmena, JG Clohessy, KA Webster, ... Nature genetics 45 (7), 747-755, 2013 | 171 | 2013 |
| Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice KM Smith, S Matson, WR Matson, K Cormier, SJ Del Signore, SW Hagerty, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (6), 616-626, 2006 | 169 | 2006 |
| Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice EC Stack, KM Smith, H Ryu, K Cormier, M Chen, SW Hagerty, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (3), 373-380, 2006 | 147 | 2006 |
| Modulation of nucleosome dynamics in Huntington's disease EC Stack, SJ Del Signore, R Luthi-Carter, BY Soh, DR Goldstein, ... Human molecular genetics 16 (10), 1164-1175, 2007 | 139 | 2007 |
| Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis C Grisanzio, L Werner, D Takeda, BC Awoyemi, MM Pomerantz, ... Proceedings of the National Academy of Sciences 109 (28), 11252-11257, 2012 | 135 | 2012 |
| Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice SJ Del Signore, DJ Amante, J Kim, EC Stack, S Goodrich, K Cormier, ... Amyotrophic Lateral Sclerosis 10 (2), 85-94, 2009 | 127 | 2009 |
| Morphometric studies of the aged hippocampus: I. Volumetric analysis in behaviorally characterized rats PR Rapp, EC Stack, M Gallagher Journal of Comparative Neurology 403 (4), 459-470, 1999 | 110 | 1999 |
| Quantitative analysis of immune infiltrates in primary melanoma RD Gartrell, DK Marks, TD Hart, G Li, DR Davari, A Wu, Z Blake, Y Lu, ... Cancer immunology research 6 (4), 481-493, 2018 | 109 | 2018 |
| Retromer disruption promotes amyloidogenic APP processing CP Sullivan, AG Jay, EC Stack, M Pakaluk, E Wadlinger, RE Fine, ... Neurobiology of disease 43 (2), 338-345, 2011 | 107 | 2011 |
| FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder EA Guancial, L Werner, J Bellmunt, A Bamias, TK Choueiri, R Ross, ... Cancer Medicine 3 (4), 835-844, 2014 | 101 | 2014 |
Toni ChoueiriDana-Farber Cancer Institute在 dfci.harvard.edu 的电子邮件经过验证
